Microbot Medical Sells Unregistered Equity, Dilution Risk
Ticker: MBOT · Form: 8-K · Filed: Jan 30, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Jan 30, 2024 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $6.75 million, $2,154,000, $1,100,000, $1,054,000 |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: equity-sale, dilution, capital-raise
TL;DR
**Microbot Medical just sold new shares, expect dilution.**
AI Summary
Microbot Medical Inc. entered into a material definitive agreement on January 26, 2024, involving the unregistered sale of equity securities. This filing indicates the company is raising capital by issuing new shares, which could dilute the value of existing shares. For current or prospective shareholders, this matters because an increase in the number of outstanding shares typically reduces the earnings per share and ownership percentage for existing investors, potentially impacting the stock price negatively.
Why It Matters
This filing signals potential dilution for existing shareholders as Microbot Medical Inc. is issuing new equity, which could impact the stock's per-share value.
Risk Assessment
Risk Level: medium — The unregistered sale of equity securities introduces dilution risk for current shareholders, which can negatively impact stock value.
Analyst Insight
A smart investor would monitor Microbot Medical Inc.'s stock for potential downward pressure due to dilution and research the terms of the equity sale to understand the extent of the dilution.
Key Players & Entities
- Microbot Medical Inc. (company) — registrant selling equity securities
- January 26, 2024 (date) — date of earliest event reported
FAQ
What was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on January 26, 2024.
What type of agreement did Microbot Medical Inc. enter into?
Microbot Medical Inc. entered into a Material Definitive Agreement, as reported under Item 1.01 of the 8-K filing.
What kind of securities were sold by Microbot Medical Inc.?
Microbot Medical Inc. engaged in the unregistered sales of equity securities, as indicated under Item 3.02 of the filing.
What is the business address of Microbot Medical Inc.?
The business address of Microbot Medical Inc. is 288 Grove Street, Suite 388, Braintree, MA 02184.
What is the Commission File Number for Microbot Medical Inc.?
The Commission File Number for Microbot Medical Inc. is 000-19871.
Filing Stats: 1,141 words · 5 min read · ~4 pages · Grade level 12.5 · Accepted 2024-01-30 07:20:27
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
- $6.75 million — f the SPA and return of the Plaintiffs' $6.75 million purchase price with respect to the Fina
- $2,154,000 — t, the Company agreed to pay Plaintiffs $2,154,000 (the "Total Settlement Amount"), consis
- $1,100,000 — d by the Company's insurance carrier of $1,100,000 and 1,005,965 shares of restricted Comp
- $1,054,000 — ated pursuant to the following formula: $1,054,000/[closing price of Company common stock
Filing Documents
- form8-k.htm (8-K) — 50KB
- ex10-1.htm (EX-10.1) — 106KB
- ex10-2.htm (EX-10.2) — 127KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-1_001.jpg (GRAPHIC) — 6KB
- 0001493152-24-004231.txt ( ) — 522KB
- mbot-20240126.xsd (EX-101.SCH) — 3KB
- mbot-20240126_lab.xml (EX-101.LAB) — 33KB
- mbot-20240126_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Date: January 30, 2024